Literature DB >> 20863702

Structural characteristics of thiosemicarbazones as inhibitors of melanogenesis.

Ki-Cheul Lee1, Pillaiyar Thanigaimalai, Vinay K Sharma, Min-Seok Kim, Eunmiri Roh, Bang-Yeon Hwang, Youngsoo Kim, Sang-Hun Jung.   

Abstract

A series of thiosemicarbazones 2(e-s) have been synthesized and studied their structure-activity relationship as melanogenesis inhibitor. Among them, (Z)-2-(naphthalen-1-ylmethylene)hydrazinecarbothioamide (2q, >100% inhibition at 10 μM, IC(50)=1.1 μM, ClogP=3.039) showed the strongest inhibitory activity. Regarding their structure-activity relationship, the hydrophobic substituents regardless the position on phenyl ring of benzaldehyde thiosemicarbazones enhance the inhibitory activity. Furthermore, the aromatic group of benzaldehydethiosemicarbazones can be replaced with sterically bulky cyclohexyl. Thus, hydrophobicity of the aryl or alkyl group on hydrazine of thiosemicarbazones is determinant factor for their inhibitory activity in melanogenesis rather than planarity.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20863702     DOI: 10.1016/j.bmcl.2010.08.114

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.

Authors:  Hyoeun Shin; Seung Deok Hong; Eunmiri Roh; Sang-Hun Jung; Won-Jea Cho; Sun Hong Park; Da Young Yoon; Seon Mi Ko; Bang Yeon Hwang; Jin Tae Hong; Tae-Young Heo; Sang-Bae Han; Youngsoo Kim
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 2.  Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors.

Authors:  Thanigaimalai Pillaiyar; Manoj Manickam; Vigneshwaran Namasivayam
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

3.  4-(Diphenyl-amino)-benzaldehyde 4-phenyl-thio-semicarbazone.

Authors:  Rafael Mendoza-Meroño; Laura Menéndez-Taboada; Santiago García-Granda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.